Reversal of diabetes in mice by implantation of human fibroblasts genetically engineered to release mature human insulin

Human Gene Therapy

Volumn 10, Issue 11, 1999, Pages 1753-1762

  Falqui, Luca ^a,b   Martinenghi, Sabina ^a   Severini, Giovanni M ^a   Corbella, Paola ^a   Taglietti, M Vittoria ^a   Arcelloni, Cinzia ^a   Sarugeri, Elena ^a   Monti, Lucilla D ^a   Paroni, Rita ^a   Dozio, Nicoletta ^a   Pozza, Guido ^a   Bordignon, Claudio ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; PROINSULIN; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL TRANSPLANTATION; FIBROBLAST; GENE THERAPY; GENETIC ENGINEERING; HORMONE RECEPTOR INTERACTION; HYPERGLYCEMIA; IMMUNE DEFICIENCY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN SYNTHESIS; INSULIN TREATMENT; MOUSE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; RETROVIRUS;

ANIMALIA; MURINAE; UNIDENTIFIED RETROVIRUS;

EID: 0033587485     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430349950017437     Document Type: Article

References (45)

1. ALEJANDRO, R., LEHMANN, R., RICORDI, C., KENYON, N.S., ANGELICO, M.C., BURKE, G., ESQUENAZI, V., NERY, J., BETANCOURT, A.E., KONG, S.S., MILLER, J., and MINTZ, D.H. (1997). Long-term function (6 years) of islet allografts in type 1 diabetes. Diabetes 46, 1983-1989.
2. AOKI, M., MORISHITA, R., HIGAKI, J., MORIGUCHI, A., HAYASHI, S., MATSUSHITA, H., KIDA, I., TOMITA, N., SAWA, Y, KANEDA, Y., and OGIHARA, T. (1997). Survival of grafts of genetically modified cardiac myocytes transfected with FITC-labeled oligodeoxynucleotides and the beta-galactosidase gene in the non-infarcted area, but not the myocardial infarcted area. Gene Ther. 4, 120-127.
3. ARCELLONI, C., FALQUI, L., MARTINENGHI, S., PONTIROLI, A.E., and PARONI, R. (1998). Capillary electrophoresis for simultaneous quantification of human proinsulin, insulin and intermediate forms. Electrophoresis 19, 1475-1477.
4. BELL, G.I., SWAIN, W.F., PICTET, R., CORDELL, B., GOODMAN, H.M., and RUTTER, W.J. (1979). Nucleotide sequence of a cDNA clone encoding human preproinsulin. Nature (London) 282, 525-527.
5. BONINI, C., FERRARI, G., VERZELETTI, S., SEVIDA, P., ZAPPONE, E., RUGGIERI, L., PONZONI, M., ROSSINI, S., MAVILIO, F., TRAVERSARI, C., and BORDIGNON, C. (1997). HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. Science 276, 1719-1724.
6. DAVIDSON, H.W., RHODES, C.J., and HUTTON, J.C. (1988). Intraorganellar calcium and pH control proinsulin cleavage in the pancreatic B cell via two distict site-specific endopeptidases. Nature (London) 333, 93-96.
7. DCCT RESEARCH GROUP (1987). Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual beta-cell function: Observations during eligibility testing for the diabetes control and complications trial (DCCT). J. Clin. Endocrinol. Metab. 65, 30-36.
8. DCCT RESEARCH GROUP (1993). The effect of intensive treatment of diabetes on the development and progression of long-term complication in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329, 977-986.
9. FULLER, R.S., BRAKE, A.J., and THONER, J. (1989). Intracellular targeting and structural conservation of a prohormone-processing endoprotease. Science 246, 482-486.
10. GALLOWAY, J.A., HOOPER, S.A., SPRADLIN, C.T., HOWEY, D.C., FRANK, B.H., BOWSHER, R.R., and ANDERSON, J.H. (1992). Biosynthetic human proinsulin. Review of chemistry, in vitro and in vivo receptor binding, animal and human pharmacology studies, and clinical experience. Diabetes Care 15, 666-692.
11. GROS, L., MONTOLIU, L., RIU, E., LEBRIGAND, L., and BOSCH, F. (1997). Regulated production of mature insulin by non-β-cells. Hum. Gene Ther. 8, 2249-2259.
12. GROSKREUTZ, D.J., SLIWKOWSKI, M.X., and GORMAN, C.M. (1994). Genetically engineered proinsulin constitutively processed and secreted as mature, active insulin. J. Biol. Chem. 269, 6241-6245.
13. GUGUEN-GUILLOUZO, C., and GUILLOUZO, A. (1986). Isolated and Cultured Hepatocytes. (INSERM and John Libbey, Paris and London).
14. HALBAN, P.A., and IRMINGER, J.C. (1994). Sorting and processing of secretory proteins. Biochem. J. 299, 1-18.
15. HO, S.N., HUNT, H.D., HORTON, R.M., PULLEN, J.K., and PEASE, L.R. (1989). Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77, 51-59.
16. KAHN, S.E., and HALBAN, P.A. (1997). Release of incompletely processed proinsulin is the cause of disproportionate proinsulinemia of NIDDM. Diabetes 46, 1725-1732.
17. KOLODKA, T.M., FINEGOLD, M., MOSS, L., and WOO, S.L.C. (1995). Gene therapy for diabetes mellitus in rats by hepatic expression of insulin. Proc. Natl. Acad. Sci. U.S.A. 92, 3293-3297.
18. KOTANI, H., NEWTON, P.B.I., ZHANG, S., CHIANG, Y.L., OTTO, E., WEAVER, L., BLAESE, M., ANDERSON, W.F., and McGARRlTY, G.J. (1994). Improved methods of retroviral vector transduction and production for gene therapy. Hum. Gene Ther. 5, 19-28.
19. LAMMERS, R., GRAY, A., SCHLESSINGER, J., and ULLRICH, A. (1989). Differential signalling potential of insulin and IGF-1 receptor cytoplasmic domains. EMBO J. 8, 1369-1375.
20. LANDGRAF, R. (1996). Impact of pancreas transplantation on diabetic secondary complications and quality of life. Diabetologia 39, 1415-1424.
21. LATTANZI, L., SALVATORI, G., COLETTA, M., CUSELLA DE ANGELIS, M.G., GIOGLIO, L., MURRY, C., KELLY, R., FERRARI, G., MOLINARO, M., CRESCENZI, M., MAVILIO, F., and COSSU, G. (1998). High efficiency myogenic conversion of human fibroblasts by adenoviral vector-mediated MyoD gene transfer. J. Clin. Invest. 101, 2119-2128.
22. LAUB, O., and RUTTER, W.J. (1983). Expression of the human insulin gene and cDNA in a heterologous mammalian system. J. Biol. Chem. 258, 6043-6050.
23. LAUB, O., RALL, L., BELL, G.I., and RUTTER, W.J. (1983). Expression of the human insulin gene in an alternate mammalian cell and in cell extracts. J. Biol. Chem. 258, 6034-6042.
24. LEVY, J.R., ULLRICH, A., and OLEFSKY, J.M. (1988). Endocytotic uptake, processing, and retroendocylosis of human biosynthetic proinsulin by rat fibroblasts transfected with the human insulin receptor gene. J. Clin. Invest. 81, 1370-1377.
25. LIPES, M.A., COOPER, E.M., SKELLY, R., RHODES, C.J., BOSCHETTI, E., WEIR, G.C., and DAVALLI, A.M. (1996). Insulin-secreting non-islet cells are resistant to autoimmune destruction. Proc. Natl. Acad. Sci. U.S.A. 93, 8595-8600.
26. LIU, Z., and TOWLE, H.C. (1995). Functional synergism in the carbohydrate-induced activation of the liver-type pyruvate kinase gene expression. Biochem. J. 308, 105-111.
27. LU, D., TAMEMOTO, H., SHIBATA, H., SAITO, I., and TAKEUCHI, T. (1998). Regulatable production of insulin from primary-cultured hepatocytes: Insulin is up-regulated by glucagon and cAMP and down-regulated by insulin. Gene Ther. 5, 888-895.
28. MARKOWITZ, D., GOFF, S., and BANK, A. (1988a). Construction and use of a safe and efficient amphotropic packaging cell line. Virology 167, 400-406.
29. MARKOWITZ, D., GOFF, S., and BANK, A. (1988b). A safe packaging line for gene transfer: Separating viral genes on two different plasmids. J. Virol. 62, 1120-1124.
30. MARTINENGHI, S., DELL'ANTONIO, A., DI CARLO, V., POZZA, G., and SECCHI, A. (1997). Cancer arising after pancreas and/or kidney transplantation in a series of 99 diabetic patients. Diabetes Care 20, 272-275.
31. MILLER, D., and ROSMAN, G.J. (1989). Improved retroviral vectors for gene transfer and expression. BioTechniques 7, 980-990.
32. NEERMAN-ARBEZ, M., CIRULLI, V., and HALBAN, P.A. (1994). Levels of the conversion endoproteases PC1 (PC3) and PC2 distinguish between insulin-producing pancreatic islet beta-cells and non-beta cells. Biochem. J. 300, 57-61.
33. RHODES, C.J., and ALARCÒN, C. (1994). What beta-cell defect could lead to hyperproinsulinemia in NIDDM. Diabetes 43, 511-517.
34. RIEDEL, H., DULL, T.J., HONEGGER, A.M., SCHLESSINGER, J., and ULLRICH, A. (1989). Cytoplasmic domains determine signal specificity, cellular routing characteristics and influence ligand binding of epidermal growth factor and insulin receptors. EMBO J. 8, 2933-2954.
35. RUDONI, S., MARTINENGHI, S., SEVERINI, G.M., MONTI, L.D., POZZA, G., BORDIGNON, G., and FALQUI, L. (1998). Glucose-induced activity of liver-type pyruvate kinase promoter in prymary rat hepatocytes. Transplant. Proc. 30, 584-585.
36. RUGGIERI, L., AIUTI, A., SALOMONI, M., ZAPPONE, E., FERRARI, G., and BORDIGNON, C. (1997). Cell-surface marking of CD(34+)-restricted phenotypes of human hematopoietic progenitor cells by retrovirus-mediated gene transfer. Hum. Gene Ther. 8, 1611-1623.
37. SECCHI, A., SOCCI, C., MAFFI, P., TAGLIETTI, M.V., FALQUI, L., BERTUZZI, F., DENITTIS, P., PIEMONTI, L., SCOPSI, L., DI CARLO, V., and POZZA, G. (1997). Islet transplantation in IDDM patients. Diabetologia 40, 225-213.
38. SENDRESON, C., MARTINENGHI, S., MONTI, L.D., BORDIGNON, C., and FALQUI, L. (1999). Efficient retroviral transduction and insulin production of primary rat hepatocytes by 'flow-through' infection method. In preparation.
39. SIMONSON, G.D., GROSKREUTZ, D.J., GORMAN, C.M., and MACDONALD, M.J. (1996). Synthesis and processing of genetically modified human proinsulin by rat myoblast primary cultures. Hum. Gene Ther. 7, 71-78.
40. SUTHERLAND, D.E.R. (1993). Pancreatic transplantation: An update. Diabetes Rev. 1, 152-165.
41. TISCH, R., and McDEVITT, H. (1996). Insulin-dependent diabetes mellitus. Cell 85, 291-297.
42. VOLLENWEIDER, F., IRMINGER, J.-C., GROSS, D.J., VILLA-KOMAROFF, L., and HALBAN, P.A. (1992). Processing of proinsulin by the transfected hepatoma (FAO) cells. J. Biol. Chem. 267, 14629-14636.
43. VOLLENWEIDER, F., KAUFMAN, J., IRMINGER, J.-C., and HALBAN, P.A. (1995). Processing of proinsulin by furin, PC2, and PC3 in (co)transfected COS (monkey kidney) cells. Diabetes 44, 1075-1080.
44. YAZIGI, N.A., CARRICK, T.L., BUCUVALAS, J.C., SCHMIDT, C.S., BALISTRIERI, W.F., and BEZERRA, J.A. (1997). Expansion of transplanted hepatocytes during liver regeneration. Transplantation 64, 816-820.
45. YOSHIMOTO, K., MURAKAMI, R., MORITANI, M., OHTA, M., IWAHANA, H., NAKAUCHI, H., and ITAKURA, M. (1996). Loss of ganciclovir sensitivity by exclusion of thymidine kinase gene from transplanted proinsulin-producing fibroblasts as a gene therapy model for diabetes. Gene Ther. 3, 230-234.